HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pergolide: a dopamine agonist at both D1 and D2 receptors.

Abstract
Pergolide is a potent, direct-acting dopamine agonist used in treating Parkinson's disease. It is an agonist found recently to have high affinity for D3 receptors. The affinity of pergolide for D1 receptors is lower than for D2 receptors, and there have been some reports that it may not interact with D1 receptors in vivo at doses used to activate D2 receptors. A growing body of evidence suggests that pergolide does occupy and activate D1 receptors in vivo, although the relevance to therapeutic efficacy in Parkinson's disease needs further study.
AuthorsR W Fuller, J A Clemens
JournalLife sciences (Life Sci) Vol. 49 Issue 13 Pg. 925-30 ( 1991) ISSN: 0024-3205 [Print] Netherlands
PMID1832202 (Publication Type: Journal Article, Review)
Chemical References
  • Receptors, Dopamine
  • Receptors, Dopamine D1
  • Receptors, Dopamine D2
  • Pergolide
Topics
  • Animals
  • In Vitro Techniques
  • Pergolide (pharmacology)
  • Receptors, Dopamine (drug effects)
  • Receptors, Dopamine D1
  • Receptors, Dopamine D2

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: